The KTH Center for Applied Precision Medicine (KCAP)

The KTH Center for Applied Precision Medicine (KCAP) was initiated during 2015 as a research center funded by the Erling-Persson Family Foundation . The center is hosted by the School of Biotechnology at the Royal Institute of Technology (KTH) and it is located at the Science for Life Laboratory (SciLifeLab)  in proximity to the campus of Karolinska Institutet   in Stockholm.

The objective of KCAP is to perform antibody-based translational medicine with a focus on applied proteomics. The aim is to take advantage of the biobank resources in Sweden to develop and apply new technologies for personalised medicine through biomarker discovery for stratification of patients and studies of normal physiology and disease pathology.

KCAP is working in close collaboration with one of the world’s largest antibody resources, the Human Protein Atlas program. With access to more than 45 000 antibodies and recombinant human protein fragments, the center is developing high-performance protein analysis technologies to enhance accuracy and sensitivity beyond that of existing detection techniques.

KCAP is organised into six research programs led by Principal Investigators that together with the Center Director have the strategic and scientific responsibility for the center.

  1. Wellness profiling in collaboration with the SCAPIS project
  2. Applied clinical proteomics
  3. Validation of antibodies
  4. Nanobiotechnology
  5. Plasma Atlas
  6. Brain Atlas

Belongs to: The KTH Center for Applied Precision Medicine (KCAP)
Last changed: Jan 22, 2018